BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fouad SA, Esmat S, Omran D, Rashid L, Kobaisi MH. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection. World J Gastroenterol 2012; 18(23): 2988-2994 [PMID: 22736923 DOI: 10.3748/wjg.v18.i23.2988]
URL: https://www.wjgnet.com/1007-9327/full/v18/i23/2988.htm
Number Citing Articles
1
Tomas Koller, Jana Kollerova, Martin Huorka, Iveta Meciarova, Juraj Payer. Noninvasive scoring algorithm to identify significant liver fibrosis among treatment-naive chronic hepatitis C patientsEuropean Journal of Gastroenterology & Hepatology 2014; 26(10) doi: 10.1097/MEG.0000000000000182
2
Iraj Shahramian, Manijeh Khalili, Alireza Sargazi, Alireza Dechal, Mostafa Bazi, Masoud Jahantigh, Mojtaba Delaramnasab, Ali Bazi. Non-Invasive Markers of Liver Fibrosis in Children with Chronic Hepatic DisordersGene, Cell and Tissue 2020; 7(3) doi: 10.5812/gct.101443
3
Hanan Mahmoud Fayed, Hasan Sedeek Mahmoud, Abdallah Elaiw Mohamed Ali. <p>The Utility of Retinol-Binding Protein 4 in Predicting Liver Fibrosis in Chronic Hepatitis C Patients in Response to Direct-Acting Antivirals</p>Clinical and Experimental Gastroenterology 2020;  doi: 10.2147/CEG.S229689
4
Baris Yilmaz, Huseyin Kayadibi, Abdullah O. Yeniova, Huseyin Koseoglu, Zahide Simsek. The age, bilirubin and albumin (ABA) index: a novel noninvasive index for predicting liver fibrosis in patients with chronic hepatitis C infectionEuropean Journal of Gastroenterology & Hepatology 2021; 33(1S) doi: 10.1097/MEG.0000000000002038
5
Bassel K. El-Zorkany, Sherif M. Gamal, Sherine A. El-Mofty. Frequency and causes of discontinuation of methotrexate in a cohort of Egyptian patientsThe Egyptian Rheumatologist 2013; 35(2) doi: 10.1016/j.ejr.2013.01.003
6
María Jesús Andrés-Otero, José Manuel Lou-Bonafonte, Jesús Escanero-Marcén, Trinidad Serrano-Aulló, Juan José Puente-Lanzarote. Biomarcadores, índices y algoritmos para el diagnóstico de fibrosis hepática en pacientes con hepatitis crónica por virus CRevista del Laboratorio Clínico 2015; 8(4) doi: 10.1016/j.labcli.2015.07.004
7
Ragesh B. Thandassery, Saad Al Kaabi, Madiha E. Soofi, Syed A. Mohiuddin, Anil K. John, Muneera Al Mohannadi, Khalid Al Ejji, Rafie Yakoob, Moutaz F. Derbala, Hamidullah Wani, Manik Sharma, Nazeeh Al Dweik, Mohammed T. Butt, Yasser M. Kamel, Khaleel Sultan, Fuad Pasic, Rajvir Singh. Mean Platelet Volume, Red Cell Distribution Width to Platelet Count Ratio, Globulin Platelet Index, and 16 Other Indirect Noninvasive Fibrosis ScoresJournal of Clinical Gastroenterology 2016; 50(6) doi: 10.1097/MCG.0000000000000489
8
María Jesús Andrés-Otero, Ignacio De-Blas-Giral, Juan José Puente-Lanzarote, Trinidad Serrano-Aulló, María José Morandeira, Sara Lorente, José Manuel Lou-Bonafonte. Multiple approaches to assess fourteen non-invasive serum indexes for the diagnosis of liver fibrosis in chronic hepatitis C patientsClinical Biochemistry 2016; 49(7-8) doi: 10.1016/j.clinbiochem.2015.12.017
9
Keyur Patel, Sumeet K. Asrani, Maria Isabel Fiel, Deborah Levine, Daniel H. Leung, Andres Duarte-Rojo, Jonathan A. Dranoff, Tarek Nayfeh, Bashar Hasan, Tamar H. Taddei, Yahya Alsawaf, Samer Saadi, Abdul Mounaem Majzoub, Apostolos Manolopoulos, Muayad Alzuabi, Jingyi Ding, Nigar Sofiyeva, Mohammad H. Murad, Mouaz Alsawas, Don C. Rockey, Richard K. Sterling. Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice GuidelineHepatology 2025; 81(1) doi: 10.1097/HEP.0000000000000842
10
Hossein Keyvani, Mehdi Fazlalipour, Seyed Hamid Reza Monavari, Hamid Reza Mollaie. Hepatitis C Virus - Proteins, Diagnosis, Treatment and New Approaches for Vaccine DevelopmentAsian Pacific Journal of Cancer Prevention 2012; 13(12) doi: 10.7314/APJCP.2012.13.12.5917
11
Ahmed Cordie, Ahmed Salama, Marwa El‐Sharkawy, Saeed M. El‐Nahaas, Marwa Khairy, Aisha Elsharkawy, Mohamed Hassany, Gamal Esmat. Comparing the efficiency of Fib‐4, Egy‐score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis CJournal of Medical Virology 2018; 90(6) doi: 10.1002/jmv.25064
12
Shelley S Selph, Alexander D Ginsburg, Roger Chou. Impact of contacting study authors to obtain additional data for systematic reviews: diagnostic accuracy studies for hepatic fibrosisSystematic Reviews 2014; 3(1) doi: 10.1186/2046-4053-3-107
13
Basem Hasan Elesawy, Amal Abd El hafez, Laila Shehata Dorgham, Ahmad El-Askary. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoringPathology - Research and Practice 2014; 210(12) doi: 10.1016/j.prp.2014.07.005
14
Ahmet Tarik Eminler, Talat Ayyildiz, Kader Irak, Murat Kiyici, Selim Gurel, Enver Dolar, Macit Gulten, Selim G. Nak. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patientsEuropean Journal of Gastroenterology & Hepatology 2015; 27(12) doi: 10.1097/MEG.0000000000000468
15
Lamiaa Mobarak, Dalia Omran, Mohammed M. Nabeel, Zeinab Zakaria. Fibro markers for prediction of hepatocellular carcinoma in Egyptian patients with chronic liver diseaseJournal of Medical Virology 2017; 89(6) doi: 10.1002/jmv.24720
16
AM Attallah, MS Albannan, MM Omran, R Zayed, S Saif, A Farid, M Hassany, A Yosry, D Omran. A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosisBritish Journal of Biomedical Science 2019; 76(3) doi: 10.1080/09674845.2019.1600325
17
Shiow-Ling Wu, Sheng-Chang Wang, Hsiao-Hui Tsou, Hsiang-Wei Kuo, Ing-Kang Ho, Sheng-Wen Liu, Ya-Ting Hsu, Yao-Sheng Chang, Yu-Li Liu, Golo Ahlenstiel. Hepatitis C Virus Infection Influences the S-Methadone Metabolite Plasma ConcentrationPLoS ONE 2013; 8(7) doi: 10.1371/journal.pone.0069310
18
Anna Egresi, Gabriella Lengyel, Krisztina Hagymási. Options of non-invasive assessment of liver fibrosis based on the clinical dataOrvosi Hetilap 2015; 156(2) doi: 10.1556/OH.2015.30069
19
Dong Lv, Yanfu Guo, Xia Li, Li Zhang. Increased transferase ratio is associated with adverse cardio-cerebral events in patients with unstable angina: A retrospective cohort studyMedicine 2023; 102(31) doi: 10.1097/MD.0000000000034563
20
Banu D. Ozel, Orhan K. Poyrazoğlu, Ahmet Karaman, Hatice Karaman, Engin Altinkaya, Eylem Sevinç, Gökmen Zararsiz. The PAPAS indexEuropean Journal of Gastroenterology & Hepatology 2015; 27(8) doi: 10.1097/MEG.0000000000000379
21
Ayfer BAKIR, Mustafa GÜNEY, Harun ERDAL, Özlem YAVUZ, Armağan GÜNAL, Mustafa GÜLŞEN, Mehmet Tevfik YAVUZ. Assessment of The Performances of Hepatitis C Virus Viral Markers, Age-Platelet Index and Aspartate aminotransferase to Alanine Aminotransferase Ratio Scores, in Predicting Liver HistopathologyTurkish Journal of Internal Medicine 2021; 3(1) doi: 10.46310/tjim.825814
22
Natalie Zahr, Allison J. Kwong. Serum Biomarkers of Liver Fibrosis Identify Globus Pallidus VulnerabilitySSRN Electronic Journal 2022;  doi: 10.2139/ssrn.4194649
23
Roger Chou, Ngoc Wasson. Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus InfectionAnnals of Internal Medicine 2013; 158(11) doi: 10.7326/0003-4819-158-11-201306040-00005
24
Bassem Refaat, Adel Galal El-Shemi, Ahmed Mohamed Ashshi, Adnan AlZanbagi. Serum Activins and Follistatin during the Treatment of Chronic Hepatitis C Genotypes 1 and 4 and Their Correlations with Viral Load and Liver Enzymes: A Preliminary ReportGastroenterology Research and Practice 2014; 2014 doi: 10.1155/2014/628683
25
Natalie M. Zahr, Kent E. Vrana. Peripheral TNFα elevations in abstinent alcoholics are associated with hepatitis C infectionPLOS ONE 2018; 13(2) doi: 10.1371/journal.pone.0191586
26
Allison J. Kwong, Natalie M. Zahr. Serum biomarkers of liver fibrosis identify globus pallidus vulnerabilityNeuroImage: Clinical 2023; 37 doi: 10.1016/j.nicl.2023.103333
27
P Debnath, S Nair, P Rathi, P Junare, S Jain, S Chandnani, A Singh, Q Contractor. Serum biomarkers as an alternative to vibration controlled transient elastography in liver fibrosis staging in chronic hepatitis CActa Gastro Enterologica Belgica 2021; 84(1) doi: 10.51821/84.1.776
28
Bassel El-Zorkany, Abir Mokbel, Sherif M. Gamal, Maha Mousa, Mohamed Youssef, Ihsane Hmamouchi. Comparison of comorbidities of the Egyptian rheumatoid arthritis patients to the global cohort of the COMORA study: a post-hoc analysisClinical Rheumatology 2016; 35(5) doi: 10.1007/s10067-015-3142-4
29
Shahira El-Etreby. Fibrosis 4 Score Versus Hyaluronic Acid as Non-Invasive Tools for Assessment of HCV-Related Hepatic Fibrosis: Correlation with Quantitative Morphometric Analysis of Liver BiopsyGastroenterology & Hepatology: Open Access 2016; 5(2) doi: 10.15406/ghoa.2016.05.00134
30
Hanan M. Fayed, Ali A. Ghweil, Mona M. AbdelMeguid. Daclatasvir and Sofosbuvir Therapy Enhance Monocyte Phenotypic Changes in Naive Chronic Hepatitis C Patients: A Prospective Cohort StudyInterdisciplinary Perspectives on Infectious Diseases 2019; 2019 doi: 10.1155/2019/9469567
31
Eman Abdelsameea, Ayman Alsebaey, Wael Abdel-Razek, Nermin Ehsan, Wesam Morad, Mohsen Salama, Imam Waked. Elastography and serum markers of fibrosis versus liver biopsy in 1270 Egyptian patients with hepatitis CEuropean Journal of Gastroenterology & Hepatology 2020; 32(12) doi: 10.1097/MEG.0000000000001672
32
Natalie M. Zahr, Kilian M. Pohl, Allison J. Kwong, Edith V. Sullivan, Adolf Pfefferbaum. Preliminary Evidence for a Relationship between Elevated Plasma TNFα and Smaller Subcortical White Matter Volume in HCV Infection Irrespective of HIV or AUD ComorbidityInternational Journal of Molecular Sciences 2021; 22(9) doi: 10.3390/ijms22094953
33
Monika Gudowska, Ewa Gruszewska, Anatol Panasiuk, Bogdan Cylwik, Magdalena Świderska, Robert Flisiak, Maciej Szmitkowski, Lech Chrostek. Selected Noninvasive Markers in Diagnosing Liver DiseasesLaboratory Medicine 2016; 47(1) doi: 10.1093/labmed/lmv015
34
Xiaobo Liu, Peng Liu. Elevated AST/ALT ratio is associated with all-cause mortality in patients with stable coronary artery disease: a secondary analysis based on a retrospective cohort studyScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-13355-2
35
Minal J Sangwaiya, David IN Sherman, David J Lomas, Philip J Shorvon. Latest developments in the imaging of fibrotic liver diseaseActa Radiologica 2014; 55(7) doi: 10.1177/0284185113510159
36
Bassem Refaat, Ahmed Mohammed Ashshi, Adel Galal El-Shemi, Adnan AlZanbagi. Effects of chronic hepatitis C genotype 1 and 4 on serum activins and follistatin in treatment naïve patients and their correlations with interleukin-6, tumour necrosis factor-α, viral load and liver damageClinical and Experimental Medicine 2015; 15(3) doi: 10.1007/s10238-014-0297-2